Thus, ATM knockdown sensitized several lung cancer cell lines with different genetic backgrounds to MEK inhibition, and even augmented the response of already sensitive BRAF mutant H1755 cells by an order of magnitude. This evidence concerns the gene MAP2K7 and lung carcinoma.